Melek Karadag-Assem
Research Assistant (NTAD)
Melek works on the DPUK-funded New Therapeutics in Alzheimer's Disease (NTAD) research study, which aims to identify early biomarkers for Alzheimer's disease using MEG and EEG brain imaging techniques. She is based at the Cambridge Centre for Frontotemporal Dementia and Related Disorders at the University of Cambridge.
Prior to working at Cambridge, Melek completed a master's degree at the Basque Center On Cognition, Brain and Language.